Abstract
BackgroundAccurate monitoring of disease activity in early PsA is limited by the potential underestimation of inflammation by clinical examination and the absence of disease-specific biochemical markers. Therefore, sensitive and reliable...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
